ESC 365 - Heart failure as a serious but preventable complication of T2DM (Type 2 Diabetes Mellitus) – metabolic physician perspective.

Open Access

Heart failure as a serious but preventable complication of T2DM (Type 2 Diabetes Mellitus) – metabolic physician perspective.

Session: Biomarker targeted approach in preventing heart failure among patients with diabetes

Topic: Prevention

Speaker: Professor N. Sattar (Glasgow, GB)

Sponsored by Roche

Event: Heart Failure 2018

Congress Presentation

About the speaker

Professor Naveed Sattar

School of Cardiovascular and Metabolic Health, Glasgow (United Kingdom of Great Britain & Northern Ireland)

36 presentations

2 followers

3 more presentations in this session

Heart failure as a serious but preventable complication of T2DM – cardiologist perspective.

Speaker: Professor M. Pfeffer (Boston, US)

How biomarkers could help in identifying T2DM patients at risk of cardiovascular events?

Speaker: Professor M. Huelsmann (Vienna, AT)

Role of biomarkers in CVD intensive preventive therapy among T2DM - current guidelines and future perspectives.

Speaker: Professor C. Lam (Singapore, SG)

Access the full session

Biomarker targeted approach in preventing heart failure among patients with diabetes

Speakers: Professor N. Sattar, Professor M. Pfeffer, Professor M. Huelsmann, Professor C. Lam

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

Related content

Open Access

Treating the whole spectrum of heart failure.

29 August 2021

Open Access

SGLT2 Inhibitors as a Central Cardio-Renal-Metabolic Therapy: The Modern Day ACE Inhibitor.

29 August 2021

Open Access

Heart failure in context.

29 August 2021

ESC 365 is supported by